SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-767928
Filing Date
2016-11-14
Accepted
2016-11-14 17:39:56
Documents
65
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d81978d10q.htm 10-Q 748282
2 EX-31.1 d81978dex311.htm EX-31.1 8233
3 EX-31.2 d81978dex312.htm EX-31.2 8226
4 EX-32.1 d81978dex321.htm EX-32.1 4987
  Complete submission text file 0001193125-16-767928.txt   4127048

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ptgx-20160930.xml EX-101.INS 669001
6 XBRL TAXONOMY EXTENSION SCHEMA ptgx-20160930.xsd EX-101.SCH 53756
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ptgx-20160930_cal.xml EX-101.CAL 54857
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ptgx-20160930_def.xml EX-101.DEF 205487
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptgx-20160930_lab.xml EX-101.LAB 404901
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptgx-20160930_pre.xml EX-101.PRE 315183
Mailing Address 521 COTTONWOOD DRIVE, SUITE 100 MALPITAS CA 95035-7404
Business Address 521 COTTONWOOD DRIVE, SUITE 100 MALPITAS CA 95035-7404 408-649-7370
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 161996471
SIC: 2834 Pharmaceutical Preparations